IP Library › Assignment 039805/0667
Patent Assignment
Reel/Frame 039805/0667

Merger and Change of Name

Recorded: 2016-09-20 Pages: 4
Assignors
METASIGNAL THERAPEUTICS INC.
Executed: 2013-01-14
Assignee
SIGNALCHEM LIFESCIENCES CORPORATION
5600 PARKWOOD WAY, SUITE 550, RICHMOND, BC, V6V 2M2, CANADA
Covered Property (1)
Novel Sulfonamide Compounds for Inhibition of Metastatic Tumor Growth
Patent: 9,962,398 →
Application: 15/270,742 →
Publication: US 2017/0007627
Related Assignments (2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 23, 2016
From: SUPURAN, CLAUDIU; DEDHAR, SHOUKAT; MCDONALD, PAUL C.; CARTA, FABRIZIO
To: METASIGNAL THERAPEUTICS INC.
Reel/Frame 039844/0455 →
Assignment of Assignor's Interest Sep 28, 2016
From: SIGNALCHEM LIFESCIENCES CORPORATION
To: WELICHEM BIOTECH INC.
Reel/Frame 039879/0346 →